177 related articles for article (PubMed ID: 6690009)
1. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
Saad MF; Fritsche HA; Samaan NA
J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
[TBL] [Abstract][Full Text] [Related]
3. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
Rougier P; Calmettes C; Laplanche A; Travagli JP; Lefevre M; Parmentier C; Milhaud G; Tubiana M
Cancer; 1983 Mar; 51(5):855-62. PubMed ID: 6821852
[TBL] [Abstract][Full Text] [Related]
4. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
Hamada S; Ishikawa N; Yoshi M; Morita R; Fukunaga M
Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
[TBL] [Abstract][Full Text] [Related]
5. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract][Full Text] [Related]
6. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
10. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
11. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract][Full Text] [Related]
12. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
Norton JA; Doppman JL; Brennan MF
Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract][Full Text] [Related]
16. Secretion of calcitonin and carcinoembryonic antigen in long-term organ culture of human medullary thyroid carcinoma: biochemical and immunocytochemical studies.
Raue F; Boller G; Rix E; Schmidt-Gayk H; Ziegler R
Klin Wochenschr; 1985 Mar; 63(5):205-10. PubMed ID: 3990162
[TBL] [Abstract][Full Text] [Related]
17. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
[TBL] [Abstract][Full Text] [Related]
18. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.
Yokoi K; Imai T; Shibata A; Hibi Y; Kikumori T; Funahashi H; Nakao A
Endocr J; 2003 Aug; 50(4):453-8. PubMed ID: 14599120
[TBL] [Abstract][Full Text] [Related]
19. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
Ishikawa N; Hamada S
Br J Cancer; 1976 Aug; 34(2):111-5. PubMed ID: 962990
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers in C-cell cancer].
Raue F; Schmidt-Gayk H; Ziegler R
Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
